Developing therapies for common vision disorders such as glaucoma is complex – compounds must first cross into the brain before protecting neurons, all without wreaking havoc themselves. In research published in IBRO journal Neuroscience, a peptide tested in mice appears to do all these things, highlighting its potential as a treatment for glaucoma and other […] The post Peptide holds promise as a way to maintain vision of glaucoma patients appeared first on IBRO .